Kappa-opioid agonist
Kappa-opioid receptor agonist
- Analgesia without mu-type reward
- Peripherally restricted agonism → ↓ pruritus
- Central activation brings dysphoria and dissociation — the “anti-reward”
Kappa-opioid agonist (1/2)
- Anxiety, dysphoria, “anti-reward”
- Moderate analgesia
- Antipruritic (anti-itch)
- Sedation
Kappa-opioid agonist (2/2)
- Hallucinogenic at high dose
- ↓ post-anesthesia shivering
- Inhibition of orexin neurons
Drugs with this mechanism (9)
- Butorphanol — Mixed opioid agonist-antagonist; intranasal analgesia can precipitate opioid withdrawal.
- Difelikefalin — Peripheral kappa-opioid agonist for uremic itch; minimal CNS effects.
- Dynorphin — Endogenous kappa-opioid peptide linked to dysphoria.
- Eluxadoline — Gut-focused mixed opioid for IBS-D; contraindicated without a gallbladder.
- Ibogaine — Psychoactive alkaloid studied for addiction; cardiac (QT) risk.
- Nalbuphine — Mixed opioid agonist-antagonist analgesic with a ceiling on respiratory depression.
- Noribogaine — Long-acting active metabolite of ibogaine.
- Pentazocine — Mixed opioid agonist-antagonist; can precipitate withdrawal.
- Salvinorin A — The potent kappa-opioid psychedelic of Salvia divinorum; non-nitrogenous.
All mechanisms · Open Kappa-opioid agonist in the interactive console ↗